xIPOmeter
PharmEasy
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
News related to PharmEasy94
PharmEasyPharmEasy's $5.6 billion value shrinks to $456 million, investor data ...
The British American global asset firm's Global Research Fund values its holding of 12.9 million shares in PharmEasy at $766,043, according to its latest filing ...
https://www.msn.com/en-us/money/companies/pharmeasy-s-56-billion-value-shrinks-to-456-million-investor-data-shows/ar-AA1wvrJUPharmEasyPharmEasy investor cuts value of its stake drastically, implying new ...
Indian online pharmacy PharmEasy is now being valued at about $456 million after its investor Janus Henderson said in a filing that it valued its stake of ...
https://techcrunch.com/2024/12/25/pharmeasy-valued-at-456-million-vs-peak-5-6-billion-investor-data-shows/PharmEasyPharmEasy's $5.6 billion value shrinks to $456 million, investor data ...
The British American global asset firm's Global Research Fund values its holding of 12.9 million shares in PharmEasy at $766,043, according to its latest filing ...
https://finance.yahoo.com/news/pharmeasys-5-6-billion-value-064920424.htmlPharmEasyPharmEasy further loses its valuation to $456 million: Report By IANS
New Delhi, Dec 26 (IANS) Health-tech company PharmEasy has drastically lost its valuation to now around $456 million, from its all-time high of $5.6 billion ...
https://in.investing.com/news/stock-market-news/pharmeasy-further-loses-its-valuation-to-456-million-report-4590373PharmEasyPharmEasy halves loss to Rs 2,533 crore in FY24, revenue dips 15%
Mumbai-based PharmEasy, operated by API Holdings Limited, reported a net loss of Rs 2533 crore, an improvement from the Rs 5212 crore loss in FY23, ...
https://www.msn.com/en-in/money/markets/pharmeasy-halves-loss-to-rs-2-533-crore-in-fy24-revenue-dips-15/ar-AA1uu9M1
Show more (89)Investors5
Temasek Holdings
Tiger Global Management
B Capital Group
F-Prime Capital
Bessemer Venture Partners